Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Invested Capital (2018 - 2025)

Inventiva (IVA) posted quarterly Invested Capital of $302.2 million for Q4 2025, up 31.89% year-over-year from $229.2 million in Q4 2024, and up 55.13% quarter-over-quarter from $194.8 million in Q2 2025.

Analysis

Inventiva (IVA) Invested Capital (2018 - 2025) Analysis & Trends

Inventiva's Invested Capital history runs 8 years deep, the most recent figure standing at $302.2 million for Q4 2025.

  • In Q4 2025, Invested Capital rose 31.89% year-over-year to $302.2 million; the TTM figure through Dec 2025 stood at $844.7 million (up 89.23% YoY), while the FY2025 annual figure was $302.2 million, up 31.89% from the prior year.
  • Invested Capital for Q4 2025 stood at $302.2 million, up from $194.8 million in the prior quarter.
  • The five-year high for Invested Capital was $302.2 million in Q4 2025, with the low at $31.7 million in Q4 2021.
  • The 5-year median for Invested Capital is $108.6 million (2023), against an average of $139.8 million.
  • The sharpest annual moves came in 2021 and 2024: Invested Capital soared 31.73% in 2021, then soared 132.04% in 2024.
  • Inventiva's Invested Capital stood at $31.7 million in 2021, then soared by 105.28% to $65.1 million in 2022, then soared by 51.81% to $98.8 million in 2023, then jumped by 132.04% to $229.2 million in 2024, then soared by 31.89% to $302.2 million in 2025.
  • Business Quant data shows IVA's Invested Capital at $302.2 million in Q4 2025, $194.8 million in Q2 2025, and $229.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Inventiva 893.85 Mn 893.85 Mn - -33.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -33.13 Bn
Jun 30, 2025 102.41 Mn
Dec 31, 2024 48.51 Mn
Jun 30, 2024 -13.91 Mn
Dec 31, 2023 20.47 Mn
Jun 30, 2023 38.90 Mn
Dec 31, 2022 91.69 Mn
Jun 30, 2022 94.18 Mn
Dec 31, 2021 113.24 Mn
Jun 30, 2021 118.76 Mn
Mar 31, 2021 135.51 Mn
Dec 31, 2020 144.58 Mn
Jun 30, 2020 57.01 Mn
Dec 31, 2019 45.94 Mn
Dec 31, 2018 70.73 Mn